Alx Oncology Holdings Stock Price on April 15, 2024
| ALXO Stock | USD 1.83 0.04 2.14% |
Below is the normalized historical share price chart for Alx Oncology Holdings extending back to July 17, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alx Oncology stands at 1.83, as last reported on the 27th of December, with the highest price reaching 1.97 and the lowest price hitting 1.75 during the day.
If you're considering investing in Alx Stock, it is important to understand the factors that can impact its price. Alx Oncology appears to be unstable, given 3 months investment horizon. Alx Oncology Holdings secures Sharpe Ratio (or Efficiency) of 0.0338, which signifies that the company had a 0.0338% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Alx Oncology Holdings, which you can use to evaluate the volatility of the firm. Please makes use of Alx Oncology's Mean Deviation of 4.74, downside deviation of 6.71, and Risk Adjusted Performance of 0.0191 to double-check if our risk estimates are consistent with your expectations.
At this time, Alx Oncology's Total Stockholder Equity is very stable compared to the past year. As of the 27th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 254.7 M, while Common Stock Total Equity is likely to drop about 28.2 K. . At this time, Alx Oncology's Price To Sales Ratio is very stable compared to the past year. As of the 27th of December 2024, Price Book Value Ratio is likely to grow to 3.54, while Price Earnings Ratio is likely to drop (4.18). Alx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of July 2020 | 200 Day MA 6.2749 | 50 Day MA 1.5051 | Beta 1.036 |
Alx |
Sharpe Ratio = 0.0338
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALXO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.58 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Alx Oncology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alx Oncology by adding it to a well-diversified portfolio.
Price Book 0.6515 | Enterprise Value Ebitda (2.35) | Price Sales 5.9 K | Shares Float 27.1 M | Wall Street Target Price 7.6667 |
Related Headline
Crinetics Pharmaceuticals Headline on 15th of April 2024
Disposition of 20000 shares by Struthers Richard Scott of Cr... by Struthers Richard Scott
Filed transaction by Crinetics Pharmaceuticals Director, Officer: President & Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Alx Oncology Valuation on April 15, 2024
It is possible to determine the worth of Alx Oncology on a given historical date. On April 15, 2024 Alx was worth 13.1 at the beginning of the trading date compared to the closed value of 12.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alx Oncology stock. Still, in general, we apply an absolute valuation method to find Alx Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alx Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alx Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 13.32 | 13.63 | 12.51 | 13.03 | 359,332 | |
04/15/2024 | 13.10 | 13.10 | 12.12 | 12.89 | 328,161 |
| 12.83 | 14.61 | 12.83 | 14.49 | 1,546,281 |
| Backtest Alx Oncology | | | Alx Oncology History | | | Alx Oncology Valuation | Previous | Next |
Alx Oncology Trading Date Momentum on April 15, 2024
| On April 16 2024 Alx Oncology Holdings was traded for 14.49 at the closing time. The top price for the day was 14.61 and the lowest listed price was 12.83 . The trading volume for the day was 1.5 M. The trading history from April 16, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 12.41% . The overall trading delta against the current closing price is 24.52% . |
Alx Oncology Holdings Fundamentals Correlations and Trends
By evaluating Alx Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alx Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alx Oncology Stock history
Alx Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alx Oncology Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alx Oncology stock prices may prove useful in developing a viable investing in Alx Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43 M | 40.8 M | |
| Net Loss | -111.1 M | -105.6 M |
Alx Oncology Quarterly Net Working Capital |
|
Alx Oncology Stock Technical Analysis
Alx Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alx Oncology Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Alx Oncology Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Alx Oncology December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Alx Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alx Oncology shares will generate the highest return on investment. By undertsting and applying Alx Oncology stock market strength indicators, traders can identify Alx Oncology Holdings entry and exit signals to maximize returns
Alx Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alx Oncology's price direction in advance. Along with the technical and fundamental analysis of Alx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0191 | |||
| Jensen Alpha | 0.08 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0048 | |||
| Treynor Ratio | (0.72) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.97) | Quarterly Revenue Growth (1.00) | Return On Assets (0.49) | Return On Equity (0.99) |
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.